Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04579913 · ClinicalTrials.gov registry record
A Multi-center, International Prospective Follow up Study
A clinical trial, sponsored by Medi-Tate.
- Terminated
- Registry status
- 17
- Enrollment target
NCT04579913: Clinical Trial study, sponsored by Medi-Tate.
NCT04579913 is a clinical trial that was terminated before completion, run by Medi-Tate. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04579913 was terminated before completion, sponsored by Medi-Tate.
- TERMINATED
- Registry status
- 17 participants
- Enrollment target
Study Summary
The study objective is to assess the safety and efficacy of iTind three to five years following treatment.
Primary Outcome
The primary endpoint of the study is time to first alternative surgical BPH intervention, defined as the time (in months) from the iTind procedure to intervention.
Interventions
- OTHER Review of medical history, administration of questionnaires, uroflowmetry and PVR as measured by ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2020-12-21 |
| Est. Completion | 2021-04-22 |
Why NCT04579913 stopped before completion
NCT04579913 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 17 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Review of medical history, administration of questionnaires, uroflowmetry and PVR as measured by ultrasound is the first listed.
NCT04579913 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04579913 about?
NCT04579913 is a clinical study titled "A Multi-center, International Prospective Follow up Study". The study objective is to assess the safety and efficacy of iTind three to five years following treatment.
What is the current status of trial NCT04579913?
This trial is currently terminated. The enrollment target is 17 participants. The study started on 2020-12-21. Estimated completion is 2021-04-22.
What interventions are being tested in trial NCT04579913?
The interventions under investigation include: Review of medical history, administration of questionnaires, uroflowmetry and PVR as measured by ultrasound (OTHER).
Who is sponsoring clinical trial NCT04579913?
This trial is sponsored by Medi-Tate, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI